The B7 homolog 3 (CD276 or B7-H3), a member of the B7 immune checkpoint family is rather specifically expressed in many human cancers, including glioma, ovarian cancer, neuroblastoma, lung adenocarcinoma, pancreatic cancer, certain sarcomas, and AML. Here, CD276 is linked to cancer.